Cargando…

Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates

Leiomyosarcoma (LMS) is a malignant soft tissue sarcoma (STS) with a dismal prognosis following metastatic disease. Chemotherapeutic intervention has demonstrated to have modest clinical efficacy with no curative potential in LMS patients. Previously, we demonstrated pan-HDAC inhibition to have a su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez, Gonzalo, Braggio, Danielle, Zewdu, Abeba, Casadei, Lucia, Batte, Kara, Bid, Hemant Kumar, Koller, David, Yu, Peter, Iwenofu, Obiajulu Hans, Strohecker, Anne, Choy, Edwin, Lev, Dina, Pollock, Raphael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706733/ https://www.ncbi.nlm.nih.gov/pubmed/29186204 http://dx.doi.org/10.1371/journal.pone.0188859

Ejemplares similares

Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis
por: Zewdu, A, et al.
Publicado: (2016)

HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)
por: Lopez, Gonzalo, et al.
Publicado: (2015)

β-catenin S45F mutation results in apoptotic resistance
por: Braggio, Danielle, et al.
Publicado: (2020)

Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors
por: Braggio, Danielle Almeida, et al.
Publicado: (2022)

SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy
por: Choy, Edwin, et al.
Publicado: (2018)

Corrigendum to “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy”
por: Choy, Edwin, et al.
Publicado: (2019)

miR-133a function in the pathogenesis of dedifferentiated liposarcoma
por: Yu, Peter Y., et al.
Publicado: (2018)

HER2-positive Metastatic Melanoma: A Cautionary Tale!
por: Cui, Xiaoyan, et al.
Publicado: (2020)

Mocetinostat activates Krüppel-like factor 4 and protects against tissue destruction and inflammation in osteoarthritis
por: Kawata, Manabu, et al.
Publicado: (2023)

ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
por: Meidhof, Simone, et al.
Publicado: (2015)

Prostate-Specific Membrane Antigen Targeted Polymersomes for Delivering Mocetinostat and Docetaxel to Prostate Cancer Cell Spheroids
por: Karandish, Fataneh, et al.
Publicado: (2016)

Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes
por: Grivas, Petros, et al.
Publicado: (2018)

Metastatic sporadic paraganglioma with EWSR1::CREM gene fusion: A unique molecular profile that expands the phenotypic diversity of the molecular landscape of the EWSR1::CREM gene fusion positive tumors
por: Javaid, Sehrish, et al.
Publicado: (2022)

Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma
por: Mittal, Sonam, et al.
Publicado: (2023)

Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines
por: Lopez-Acevedo, Micael, et al.
Publicado: (2014)

HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation
por: Nural-Guvener, Hikmet F, et al.
Publicado: (2014)

Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure
por: Nural-Guvener, Hikmet, et al.
Publicado: (2015)

Class I HDAC inhibitor mocetinostat induces apoptosis by activation of miR-31 expression and suppression of E2F6
por: Zhang, Q, et al.
Publicado: (2016)

In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting
por: Kaya Çakir, Hacer, et al.
Publicado: (2021)

Link between p53 isoforms and angiogenesis: Current prospects
por: Bid, Hemant Kumar
Publicado: (2013)

Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma
por: De Pas, T, et al.
Publicado: (2008)

Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma
por: Vincenzi, Bruno, et al.
Publicado: (2017)

Grade 4 Pneumonitis in a Patient Treated with a Combination of Gemcitabine and Docetaxel for Recurrent Leiomyosarcoma of the Uterus
por: Wang, Connor, et al.
Publicado: (2020)

Preclinical relevance of dosing time for the therapeutic index of gemcitabine–cisplatin
por: Li, X M, et al.
Publicado: (2005)

Cross‐flow microfiltration for isolation, selective capture and release of liposarcoma extracellular vesicles
por: Casadei, Lucia, et al.
Publicado: (2021)

A call for curricular reform: Recognising the importance of race‐based medical education
por: Inshaar, Hafza, et al.
Publicado: (2022)

Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results
por: Passardi, Alessandro, et al.
Publicado: (2017)

BET bromodomain inhibitor (JQ1) and tumor angiogenesis
por: Bid, Hemant Kumar, et al.
Publicado: (2016)

Leiomyosarcoma of the scrotum: a case report and literature review
por: Zeng, Jiping, et al.
Publicado: (2021)

A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma
por: Seddon, Beatrice, et al.
Publicado: (2015)

Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG using gemcitabine
por: Green, Adam L, et al.
Publicado: (2020)

Targeting Angiogenesis in Childhood Sarcomas
por: Bid, Hemant K., et al.
Publicado: (2011)

Vitamin D receptor and type 2 diabetes mellitus: Growing therapeutic opportunities
por: Manchanda, Parmeet Kaur, et al.
Publicado: (2012)

Induction of Krüppel‐like factor 2 reduces K/BxN serum‐induced arthritis
por: Das, Manjusri, et al.
Publicado: (2018)

Preclinical in vivo Antitumor Efficacy of Nedaplatin with Gemcitabine against Human Lung Cancer
por: Matsumoto, Mitsunobu, et al.
Publicado: (2001)

Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers
por: Fucà, Giovanni, et al.
Publicado: (2020)

Leiomyosarcoma of the Penis
por: Katsikas, Vasilios S., et al.
Publicado: (2002)

Leiomyosarcoma of the breast
por: Oktay, Y, et al.
Publicado: (2011)

Renal Leiomyosarcoma
por: Beardo, Pastora, et al.
Publicado: (2013)

Leiomyosarcoma of the Face
por: Ko, Young-Il, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hefv6ebq69q4d95na7l8v6srb6